Sandbox/osteo: Difference between revisions
< Sandbox
Amr Marawan (talk | contribs) No edit summary |
Amr Marawan (talk | contribs) No edit summary |
||
Line 39: | Line 39: | ||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5; font-weight: bold; font-style: italic;" align=center | Preferred Regimen | | style="padding: 0 5px; font-size: 90%; background: #F5F5F5; font-weight: bold; font-style: italic;" align=center | Preferred Regimen | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]] | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Vancomycin]] 40 mg divided q6-8 hours''''' <SMALL>(trough 15—20 μg/mL)</SMALL> | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftazidime]] 50 mg IV q8h'''''<BR> OR <BR> ▸ '''''[[Cefepime]] 150 mg IV q8h''''' | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 90%; background: #F5F5F5; font-weight: bold; font-style: italic;" align=center | Alternative Regimen | | style="padding: 0 5px; font-size: 90%; background: #F5F5F5; font-weight: bold; font-style: italic;" align=center | Alternative Regimen | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[ | | style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Nafcillin]]''''' <br> OR <br> ▸ '''''[[Oxcacillin]] 37mg q6h''''' | ||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | PLUS | |||
|- | |||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC" align=left | ▸ '''''[[Ceftazidime]] 2 gm IV q8h''''' <br> OR <br> '''''[[Cefepime]] 2 gm IV q12h''''' | |||
|- | |- | ||
|} | |} | ||
Line 89: | Line 93: | ||
|} | |} | ||
|} | |} | ||
Preferred regimen | |||
Vancomycin 40 mg divided q6-8 hours | |||
PLUS | |||
[[Ceftazidime]] 50 mg IV q8h <br> OR <br> [[Cefepime]] 150 mg IV q8h | |||
Alternative regimen | |||
Nafcillin or oxcacillin 37mg q6h | |||
PLUS | |||
Ceftazidime 2 gm IV q8h OR Cefepime 2 gm IV q12h | |||
Preferred regimen | |||
Vancomycin 40 mg divided q6-8 hours | |||
PLUS | |||
Ceftazidime 50 mg IV q8h OR Cefepime 150 mg IV q8h | |||
Alternative regimen | |||
Nafcillin or oxcacillin37mg q6h | |||
PLUS | |||
Ceftazidime 2 gm IV q8h OR Cefepime 2 gm IV q12h | |||
Preferred regimen | |||
Vancomycin 1 gm IV q12h, if over 100 kg, 1.5 gm IV q12h | |||
Alternative regimen | |||
Nafcillin or oxacillin 2 gm IV q4h |
Revision as of 15:18, 20 May 2014
Hematogenous Osteomyelitis
Empiric Therapy
▸ Click on the following categories to expand treatment regimens.
Age ▸ Newborn (<4 months) ▸ Children (>4 months) - Adults ▸ Adult (>21 years) |
Preferred regimen Vancomycin 40 mg divided q6-8 hours PLUS Ceftazidime 50 mg IV q8h OR Cefepime 150 mg IV q8h Alternative regimen Nafcillin or oxcacillin37mg q6h PLUS Ceftazidime 2 gm IV q8h OR Cefepime 2 gm IV q12h Preferred regimen Vancomycin 1 gm IV q12h, if over 100 kg, 1.5 gm IV q12h Alternative regimen Nafcillin or oxacillin 2 gm IV q4h |